COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,233 Articles (22,733 medRxiv, 8,500 bioRxiv)

Most recent first Previous |  Page 410: Articles 4091-4100  | Next

Machine Learning-Guided Antibody Engineering That Leverages Domain Knowledge To Overcome The Small Data Problem
Clark, T., Subramanian, V., Jayaraman, A., Fitzpatrick, E., Gopal, R., Pentakota, N., Rurak, T., Anand, S., Viglione, A., Tharakaraman, K., Raman, R., Sasisekharan, R.
10.1101/2023.06.02.543458 — Posted: 2023-06-05
A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
Yao, Y., Zhang, Y., Li, Z., Chen, Z., Wang, X., Li, Z., Yu, L., Cheng, X., Li, W., Jiang, W.-J., Wu, H.-J., Feng, Z., Sun, J., Fei, T.
10.1101/2023.06.03.543589 — Posted: 2023-06-05
A non-enzymatic test for SARS-CoV-2 RNA using DNA nanoswitches
Vilcapoma, J., Aliyeva, A., Hayden, A., Chandrasekaran, A. R., Zhou, L., Abraham Punnoose, J., Yang, D., Hansen, C., Shiu, S. C.-C., Russell, A., St. George, K., Wong, W., Halvorsen, K.
10.1101/2023.05.31.23290613 — Posted: 2023-06-04
Challenges of COVID-19 Case Forecasting in the US, 2020-2021
Lopez, V., Cramer, E. Y., Pagano, R., Drake, J. M., O'Dea, E. B., Linas, B. P., Ayer, T., Xiao, J., Adee, M., Chhatwal, J., Ladd, M. A., Mueller, P. P., Dalgic, O. O., Bracher, J., Gneiting, T., Mühlemann, A., Niemi, J., Evan, R. L., Zorn, M., Huang, Y., Wang, Y., Gerding, A., Stark, A., Jayawardena, D., Le, K., Wattanachit, N., Kanji, A. H., Castro Rivadeneira, A. J., Pei, S., Shaman, J., Yamana, T. K., Li, X., Wang, G., Gao, L., Gu, Z., Kim, M., Wang, L., Wang, Y., Yu, S., Wilson, D. J., Tarasewicz, S. R., Suchoski, B., Stage, S., Gurung, H., Baccam, S., Marshall, M., Gardner, L., Jindal, S
10.1101/2023.05.30.23290732 — Posted: 2023-06-04
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths from COVID-19: a counterfactual study on the impact of the delayed vaccination programme in Iran
Ghafari, M., Hosseinpour, S., Rezaee-Zavareh, M. S., Dascalu, S., Rostamian, S., Aramesh, K., Madani, K., Kordasti, S.
10.1101/2023.05.31.23290799 — Posted: 2023-06-04
Unveiling Womens Experiences Amidst the COVID-19 Pandemic in Nigeria: An Interpretive phenomenological analysis.
Ndu, M., Teachman, G., Martin, J., Nouvet, E.
10.1101/2023.05.30.23290724 — Posted: 2023-06-03
Carotid body dysregulation contributes to the enigma of long COVID
El-Medany, A., Adams, Z. H., Blythe, H. C., Hope, K. A., Kendrick, A. H., Abdala Sheikh, A. P., Paton, J. F., Nightingale, A. K., Hart, E. C.
10.1101/2023.05.25.23290513 — Posted: 2023-06-03
Effectiveness of mRNA-1273 bivalent (Original and Omicron BA.4/BA.5) COVID-19 vaccine in preventing hospitalizations for COVID-19, medically attended SARS-CoV-2 infections, and hospital death in the United States
Tseng, H. F., Ackerson, B. K., Sy, L. S., Tubert, J. E., Luo, Y., Qiu, S., Lee, G. S., Bruxvoort, K. J., Ku, J. H., Florea, A., Takhar, H. S., Bathala, R., Zhou, C. K., Esposito, D., Marks, M. A., Anderson, E. J., Talarico, C. A., Qian, L.
10.1101/2023.05.25.23290456 — Posted: 2023-06-03
Social inequalities in the misbelief of chloroquines protective effect against COVID-19: results from the EPICOVID-19 study in Brazil
Nunes, B., Silva, I. C., Mielke, G. I., Vidaletti, L. P., Silveira, M. F., Hallal, P.
10.1101/2023.05.29.23290677 — Posted: 2023-06-03
Deep Phenotyping of the Lipidomic Response in COVID and non-COVID Sepsis
Meng, H., Sengupta, A., Riccioti, E., Mrcela, A., Mathew, D., Mazaleuskaya, L., Ghosh, S., Brooks, T., Turner, A., Schanoski, A., Lahens, N., Tan, A. W., Woolfork, A., Grant, G., Susztak, K., Letizia, A., Sealfon, S., Wherry, E. J., Laudanski, K., Weljie, A., Meyer, N., Fitzgerald, G.
10.1101/2023.06.02.543298 — Posted: 2023-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).